Many people involved in the Foundayo clinical trials noted that, for the first time, their bodies felt as though they were working with them rather than against them
Dean OM, Gray KM, Villagonzalo KA, Dodd S, Mohebbi M, Vick T, et al
GLP-1 drug shows little benefit for people with Parkinsons disease 5 February 2025 The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinsons disease, finds a new study led by UCL researchers
For semaglutide, tirzepatide, and most long-acting GLP-1 receptor agonists, labels contain a Boxed Warning about thyroid C-cell tumor findings in rodents and contraindications for patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Best stack: NAD+ + Sermorelin For total-body support: burn more fat, sleep better, and feel like yourself again